HSD17B13 抗体 (AA 1-200)
Our Local Distributor
北京 101111
Quick Overview for HSD17B13 抗体 (AA 1-200) (ABIN7868553)
抗原
See all HSD17B13 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 1-200
-
原理
- Hydroxysteroid 17-beta dehydrogenase 13 Antibody / HSD17B13
-
纯化方法
- Protein G affinity
-
免疫原
- A portion of amino acids 1-200 of the human protein was used as the immunogen for the Hydroxysteroid 17-beta dehydrogenase 13 antibody.
-
亚型
- IgG2b, kappa
-
-
anti-Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13) (AA 20-300) antibody
HSD17B13 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13) antibodyHSD17B13 适用: 人, 大鼠 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13) (AA 81-110), (N-Term) antibodyHSD17B13 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB27107 unconjugated
anti-Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13) antibodyHSD17B13 适用: 人 WB 宿主: 兔 Monoclonal unconjugated
anti-Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13) (AA 91-140) antibodyHSD17B13 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13) (AA 81-110), (N-Term) antibodyHSD17B13 适用: 人, 小鼠 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal dilution of the Hydroxysteroid 17-beta dehydrogenase 13 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.2 mg/mL
-
缓冲液
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot the Hydroxysteroid 17-beta dehydrogenase 13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))
-
别名
- Hydroxysteroid 17-beta dehydrogenase 13
-
背景
- Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) is an engyme in the liver that is associated with lipid droplets. It is encoded by the HSD17B13 gene in humans. HSD17B13 levels increase in patients with non-alcoholic fatty liver disease (NAFLD) and can enhance lipogenesis. However, some studies have shown that loss-of-function variants in HSD17B13 may protect against the progression of NAFLD to non-alcoholic steatohepatitis, fibrosis, and hepatocellular carcinoma.
-
UniProt
- Q7Z5P4
抗原
-
